The key ingredient to effective cancer treatments
About 50 percent of cancer patients have tumors that are resistant to radiation because of low levels of oxygen—a state known as hypoxia. A startup in San Francisco is developing proteins that could carry oxygen to tumors more effectively, increasing the odds that radiation therapy will help these patients.
Last month, the National Cancer Institute (NCI) gave that startup, Omniox, $3 million in funding. Omniox is collaborating with researchers at the NCI to test whether its oxygen-carrying compounds improve radiation therapy in animals with cancer.
- CVS Ramps Up Retail Clinics with Provider Affiliations
- Drug Pricing 'Tantamount to Greed,' Lawmaker Says
- Study Puts Spotlight on Preventing Fall-Related Injuries
- Wanted: Nurse PhDs
- Contradictory Obamacare Rulings Issued by Appellate Courts
- The Infection-Busting Treatment Payers Don’t Want to Talk About
- Surgical Checklists Unused in 10% of Hospitals, CMS Data Shows
- 4 Tectonic Shifts Shaking Up Healthcare
- As HIPAA Breaches Accelerate, Tools Lag
- Ascension, Carondelet to Partner with Tenet, Dignity Health